Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities
FDA Law
SEPTEMBER 13, 2021
Today we offer the article below on one of those pieces: an HHS report released to the public last Thursday outlining the Biden Administration’s strategies on drug pricing and payment reform. Medicare negotiation authority; encourage biosimilars and generic drug utilization). Part D currently has no such cap.
Let's personalize your content